|
|
Weekly Digest
August 18, 2026
Volume 5, Issue 3
|
|
What’s Inside This Week
The federal government moved this week to dismantle the self-affirmed GRAS pathway that much of the dietary supplement ingredient supply chain has relied on since 1997. HHS and FDA unveiled a 140-page proposed rule on August 10 and published it August 11, requiring manufacturers to notify FDA of every Generally Recognized as Safe determination, with an 18-month compliance window for ingredients already on the market and a comment period running through December 9. Trade groups including CRN, AHPA, NPA and CHPA voiced support for greater transparency while warning that an underfunded FDA cannot absorb the volume, and at least one senior regulatory attorney argues the agency lacks statutory authority to require the notices at all. Elsewhere this week, India’s food regulator declared NMN an unapproved ingredient, the National Advertising Division reaffirmed unit sales as the benchmark for “#1” supplement claims, and a growing injectable wellness market raised fresh questions about where DSHEA’s boundaries actually sit.
|
|
|
|
FDA & Regulatory Action
|
WholeFoods Magazine | August 12, 2026
HHS and FDA proposed a rule requiring manufacturers to notify the agency whenever they conclude a substance added to human or animal food is Generally Recognized as Safe, with FDA making a filing determination within 45 days and completing evaluation within 360 days. Because a GRAS ingredient already in the food supply may be used in a supplement without a new dietary ingredient notification, the proposal reaches directly into the pathway many supplement ingredients travel to market. CRN warned that evaluating every new determination would add cost and unpredictable timelines, AHPA welcomed FDA’s embrace of GRAS as a pathway while pressing for adequate agency expertise, and CHPA flagged the absence of explicit federal preemption as an invitation to a state patchwork.
|
|
SupplySide Supplement Journal | August 11, 2026
Ingredients currently backed by self-affirmed GRAS dossiers would have to be submitted to FDA within 18 months of any final rule taking effect, a volume the agency may not be equipped to handle given a budget that, adjusted for inflation, is smaller than it was in 1982. UNPA president Loren Israelsen observed that the proposal “takes 140 pages to say that not much changes,” while Greenberg Traurig’s Justin Prochnow noted the rule ignores the trade secret concerns that led FDA to make notifications voluntary in the first place. Attorney Rend Al-Mondhiry pointed to FDA’s own 2016 preamble conceding it “lacks express statutory authority” to require GRAS notices, and to a 2021 federal ruling that upheld the voluntary framework.
|
|
NutraIngredients | August 14, 2026
Venable partner Todd Harrison argues the proposal exceeds FDA’s authority, because the Federal Food, Drug, and Cosmetic Act exempts substances that are GRAS, not substances that are GRAS and have filed a notification. He warns the rule offers companies no clear remedy when FDA disagrees with a determination and could “very well end the functional beverage space” if upheld. Harrison also points to the Supreme Court’s 2024 Loper Bright decision ending Chevron deference as a reason the agency will have a hard time defending the rule in court.
|
|
Food Safety News | August 12, 2026
HHS paired the GRAS proposal with the federal government’s first proposed definition of ultra-processed foods, which remains at the Office of Management and Budget with no publication timetable. Consumer groups argued the GRAS rule falls short, with Consumer Reports noting it carries no real enforcement for failing to file and does not reach chemicals already in the food supply. The Center for Science in the Public Interest emphasized that companies may still sell products before or during the notification process, preserving what it calls a fundamental flaw in the existing system.
|
|
|
|
|
NMN & Global Ingredient Status
|
NutraIngredients | August 17, 2026
India’s Food Safety and Standards Authority issued a notice dated July 24 to two Gujarat companies declaring nicotinamide mononucleotide an unapproved ingredient, naming products sold through Amazon India and 1mg. The move runs counter to the FDA’s September 2025 reversal confirming NMN is lawful in US dietary supplements, a divergence that complicates export planning for American NMN suppliers. The round-up also covers South Korea’s draft GMP and labeling rules for customized health functional foods, open for comment through August 31, and China’s draft probiotic registration rules, open through August 24.
|
|
|
|
|
Claims, Advertising & Enforcement
|
NutraIngredients | August 11, 2026
The National Advertising Division sided with Force Factor against challenger Humann over “America’s #1 Best-Selling Beets Brand,” reaffirming unit sales rather than dollar sales as the preferred metric because consumers read “#1” as bought more frequently. NAD did recommend Force Factor disclose that the claim rests on total unit sales, which the company agreed to do. The decision, handled through NAD’s expedited Fast-Track SWIFT process, sets a practical benchmark for how supplement marketers substantiate superiority claims under the self-regulatory system that operates alongside FTC oversight.
|
|
NutraIngredients | August 17, 2026
Venable attorneys Claudia Lewis and Erin Maus explain that supplement brands adding wearables, smart packaging and connected wellness products can fall under Consumer Product Safety Commission jurisdiction, with mandatory standards and immediate reporting duties that carry real penalties. Lewis cites Fitbit paying CPSC more than $12 million last year for failing to report a smartwatch burn hazard. On the FDA side, the agency’s generative AI tool Elsa is now used for inspection targeting and adverse event summarization and is being integrated with HALO, which consolidates more than 40 FDA data sources, pointing toward faster and more targeted scrutiny of supplement firms.
|
|
|
|
|
Industry, Innovation & Market
|
SupplySide Supplement Journal | August 12, 2026
Injectable and intravenous delivery is emerging as a wellness channel that sits well outside DSHEA’s definition of a dietary supplement, normalized by GLP-1 drugs and by walk-in IV clinics offering peptides such as BPC-157 and CJC-Ipamorelin. Niagen Bioscience’s Andrew Shao warns that “innovation has outpaced oversight,” with the company selling its ingredient orally as a supplement and separately as a pharmaceutical-grade injection compounded at FDA-registered 503A and 503B facilities. For DSHEA advocates, the trend illustrates how consumer demand is migrating toward formats the statute was never written to govern.
|
|
SupplySide Supplement Journal | August 12, 2026
A study in the Journal of the International Society of Sports Nutrition analyzed 2,178 user responses and found average satisfaction of 7.8 out of 10 and 98% intending to continue, even though only about 55% perceived a benefit. Cognitive support was the leading reason for use at roughly 68%, yet more than 64% reported no cognitive benefit, which researchers attribute to the common 5 gram daily dose sitting at the very bottom of the range studied for cognition. The findings underscore why structure and function claim accuracy and consumer education matter as much as ingredient quality under the DSHEA framework.
|
|
SupplySide Supplement Journal | August 11, 2026
The Organic and Natural Health Association announced a partnership with SHEFEXIL, an Indian export promotion council backed by the Ministry of Commerce and Industry that supports more than 860 products including botanical extracts and dietary ingredients. The agreement sets six priorities spanning regulatory exchange, research collaboration, quality and traceability practices, and consumer education. With India supplying a large share of the botanical raw materials used in US supplements, closer regulatory alignment has direct consequences for ingredient identity and adulteration risk under DSHEA.
|
|
|
|
|
Supply Chain & Sourcing Integrity
|
NutraIngredients | August 17, 2026
The Sustainable Herbs Initiative released Toolkit 3.0, an eight-chapter resource built from two years of working groups covering sourcing principles, supplier visits and mapping sourcing risk. Founder Ann Armbrecht urges buyers to move from transactional to reciprocal supplier relationships, and a chapter on true costs itemizes the invisible expenses of soil health, redrying, remote transport, testing and permits. Botanical supply chain documentation of this kind supports the identity and quality obligations that sit at the center of DSHEA compliance and cGMP inspections.
|
|
Food Safety News | August 14, 2026
The Safe Food Coalition asked congressional leaders to rescind a continuing resolution provision barring FDA from enforcing its 2022 food traceability rule before July 2028, pushing the original January 2026 compliance date years into the future. The letter ties the delay to an ongoing Cyclospora outbreak that has been linked to iceberg lettuce and associated with tens of thousands of illnesses. The fight over recordkeeping authority is a useful signal for supplement stakeholders, since FDA’s post-market oversight ambitions in the GRAS proposal depend on the same data infrastructure Congress has so far declined to fund.
|
|
|
Your Voice Matters
FDA’s proposed rule on mandatory GRAS notifications is open for public comment through 11:59 p.m. ET on December 9, 2026. Ingredient suppliers, manufacturers, retailers and consumers can all file comments on the record. If this rule is finalized as written, the pathway that brings most new supplement ingredients to market changes permanently. Comment now.
|
|
|
|
|
The DSHEA Weekly Digest is compiled by the DSHEA Preservation Alliance. All articles listed were published within the seven days preceding this issue and were verified at the source.
|
|
DSHEA Preservation Alliance
Protecting Lawful Supplements. Preserving Scientific Integrity.
You are receiving this email because you subscribed to updates from the DSHEA Preservation Alliance.
Unsubscribe | Update Preferences
*|LIST:ADDRESSLINE|*
Powered by PICXM
|
|
